Success Metrics

Clinical Success Rate
75.0%

Based on 9 completed trials

Completion Rate
75%(9/12)
Active Trials
0(0%)
Results Posted
67%(6 trials)
Terminated
3(21%)

Phase Distribution

Ph phase_4
6
43%
Ph phase_3
1
7%
Ph not_applicable
2
14%
Ph phase_2
2
14%

Phase Distribution

0

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
6(54.5%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(9)
Terminated(3)

Detailed Status

Completed9
Terminated3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 46 (54.5%)
N/A2 (18.2%)

Trials by Status

not_yet_recruiting214%
terminated321%
completed964%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14